The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: a Pilot Study

Active, not recruiting

• Conditions: Cancer
• Interventions: Behavioral: Cannabis (Marijuana); Behavioral: Cannabidiol (CBD)

• Registration Number: NCT05836857
• Lead Sponsor: M.D. Anderson Cancer Center

Brief Summary

To collect information about how patients in the pain management clinic use cannabis/CBD, including how often it is used, why it is used (for example, to manage pain or other symptoms), and where patients get their information on cannabis/CBD for pain management

Detailed Description

Objectives

Primary Objective:

The primary objective of this study is to investigate the prevalence of current and prior cannabis and/or CBD use in cancer patients who present to the pain management clinic at MDACC.

Secondary Objectives:

The secondary objective is to investigate the reason for cannabis/CBD use (e.g. pain, neuropsychiatric symptoms, recreational or other use), degree of symptom improvement with use, frequency of use, methods of use (e.g. inhaled vs. ingested), sources of information on cannabis/CBD, and patient interest in learning more from their physicians about cannabis/CBD for cancer pain.

Study Timeline

• Study Start: 2023-01-30
• Study First Submitted: 2023-04-19
• Study First Submitted QC: 2023-04-20
• Study First Posted: 2023-05-01
• Status Verified: 2024-09
• Last Update Submitted: 2024-09-27
• Last Update Posted: 2024-10-01
• Primary Completion: 2025-05-31
• Study Completion: 2025-05-31

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. Age 18 years or older
2. Cancer patients who present to the MD Anderson Pain Medicine Clinic as a new patient or consult
3. Willing to give informed consent
4. Willing to complete the survey

Read More

Exclusion Criteria

1. Refusal of informed consent
2. Refusal to complete the survey
3. Patients who previously completed the survey
4. Patients who opt-out or change their mind after agreeing to participate
5. Already an established patient at MDACC Pain Medicine Clinic
6. Patients scheduled to see Dr Abdi (PI).

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Cannabis (Marijuana) and Cannabidiol (CBD)	Cannabidiol (CBD)	This is a survey to determine the number of cancer pain patients who use and/or used Marijuana and/or CBD for pain or other symptom burdens.
Cannabis (Marijuana) and Cannabidiol (CBD)	Cannabis (Marijuana)	This is a survey to determine the number of cancer pain patients who use and/or used Marijuana and/or CBD for pain or other symptom burdens.

Primary Outcome Measures

Name	Time	Method
Cannabis (Marijuana) and CBD (Cannabidiol for Cancer Pain Survey	through study completion; an average of 1 year.	Score scale ranges from 1-5, Extremely interested(1),Not Interested (5)

Trial Locations

Locations (1)

M D Anderson Cancer Center; 🇺🇸 Houston, Texas, United States